Table 1: Nanomaterials used for cancer immunotherapy [25].
|
Types |
Size (nm) |
Target |
Applications |
|
Polymeric NPs |
PLGA 100-200 |
DCs |
Vaccine carrier, adjuvant |
|
Dendrimer 1-20 |
DCs |
Vaccine carrier |
|
|
Micellar 25-50 |
DCs |
Vaccine carrier |
|
|
Hydrogel 80-600 |
DCs |
Vaccine carrier |
|
|
Liposome |
100-160 |
DCs/ macrophage |
Adjuvant/Vaccine carrier |
|
Exosome |
40-100 |
T cells |
Vaccine carrier |
|
Metal NPs |
AuNPs 20-80 |
DCs |
Vaccine carrier, adjuvant |
|
IONPs |
Tumor cells |
Antibody carrier |
|
|
MSNs |
50-300 |
T cells |
Vaccine carrier |
|
CNTs |
100-200 length |
DCs |
Vaccine carrier, adjuvant |
|
VLPs |
20-100 |
DCs/macrophage |
Immunotherapy agent, Vaccine carrier |